Cargando…

Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

Detalles Bibliográficos
Autores principales:	Orlovska-Waast, Sonja, Köhler-Forsberg, Ole, Brix, Sophie Wiben, Nordentoft, Merete, Kondziella, Daniel, Krogh, Jesper, Benros, Michael Eriksen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609276/ https://www.ncbi.nlm.nih.gov/pubmed/30862938 http://dx.doi.org/10.1038/s41380-019-0381-9

Ejemplares similares

Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2018)

T11. CEREBROSPINAL FLUID (CSF) MARKERS OF INFLAMMATION AND INFECTIONS IN SCHIZOPHRENIA AND AFFECTIVE DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Orlovska, Sonja, et al.
Publicado: (2018)

Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2022)

Immunological investigations of the cerebrospinal fluid in patients with recent onset psychotic disorders: A study protocol
por: Jeppesen, Rose, et al.
Publicado: (2021)

Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2022)

Comparisons of 25 cerebrospinal fluid cytokines in a case–control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2023)

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study
por: Horsdal, Henriette Thisted, et al.
Publicado: (2017)

F137. INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AS A RISK FACTOR FOR MENTAL DISORDERS AND COGNITIVE IMPAIRMENT: A NATIONWIDE REGISTER-BASED STUDY
por: Pedersen, Emilie, et al.
Publicado: (2018)

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
por: Köhler, Ole, et al.
Publicado: (2016)

Can Exercise Increase Fitness and Reduce Weight in Patients with Schizophrenia and Depression?
por: Krogh, Jesper, et al.
Publicado: (2014)

T214. ANTIPSYCHOTIC TREATMENT PATTERNS AND EFFECTS DURING THE EARLY YEARS AMONG 316 NEWLY DIAGNOSED PATIENTS WITH SCHIZOPHRENIA FROM THE OPUS TRIAL
por: Albert, Nikolai, et al.
Publicado: (2020)

T83. SUBSTANCE-INDUCED PSYCHOSIS LINKED TO BOTH INFECTIONS AND SCHIZOPHRENIA
por: Hjorthøj, Carsten, et al.
Publicado: (2020)

The Risk of Schizophrenia and Child Psychiatric Disorders in Offspring of Mothers with Lung Cancer and Other Types of Cancer: A Danish Nationwide Register Study
por: Benros, Michael Eriksen, et al.
Publicado: (2013)

Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity
por: Speyer, Helene, et al.
Publicado: (2015)

Deep learning–based integration of genetics with registry data for stratification of schizophrenia and depression
por: Allesøe, Rosa Lundbye, et al.
Publicado: (2022)

Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial
por: Jakobsen, Ane Storch, et al.
Publicado: (2017)

The Association between Infections and General Cognitive Ability in Young Men – A Nationwide Study
por: Benros, Michael Eriksen, et al.
Publicado: (2015)

Patient-controlled hospital admission for patients with severe mental disorders: study protocol for a nationwide prospective multicentre study
por: Thomsen, Christoffer Torgaard, et al.
Publicado: (2016)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)

Exercise for patients with major depression: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2015)

Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors
por: Krebs, Morten Dybdahl, et al.
Publicado: (2021)

Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
por: Oviedo-Salcedo, Tatiana, et al.
Publicado: (2021)

SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study
por: Nersesjan, Vardan, et al.
Publicado: (2023)

Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)

The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies
por: Benrós, Michael Eriksen, et al.
Publicado: (2015)

Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis
por: Nissen, Mette Scheller, et al.
Publicado: (2019)

Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trial
por: Morthorst, Britt, et al.
Publicado: (2012)

DEMO-II Trial. Aerobic Exercise versus Stretching Exercise in Patients with Major Depression—A Randomised Clinical Trial
por: Krogh, Jesper, et al.
Publicado: (2012)

Effectiveness of the Gold Standard Programme (GSP) for smoking cessation on smokers with and without a severe mental disorder: a Danish cohort study
por: Rasmussen, Mette, et al.
Publicado: (2018)

Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2017)

Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
por: Futtrup, Jesper, et al.
Publicado: (2020)

Biomarkers in the Cerebrospinal Fluid of Patients with Psychotic Disorders Compared to Healthy Controls: A Systematic Review and Meta-Analysis
por: Rømer, T., et al.
Publicado: (2022)

Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
por: Skinningsrud, Anders, et al.
Publicado: (2008)

Postmortem Cerebrospinal Fluid Pleocytosis: A Marker of Inflammation or Postmortem Artifact?
por: Morris, James A., et al.
Publicado: (2012)

Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study
por: Oudart, Jean-Baptiste, et al.
Publicado: (2017)

The DiaS trial: dialectical behavior therapy versus collaborative assessment and management of suicidality on self-harm in patients with a recent suicide attempt and borderline personality disorder traits - study protocol for a randomized controlled trial
por: Andreasson, Kate, et al.
Publicado: (2014)

Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
por: Zanusso, Gianluigi, et al.
Publicado: (2011)

The Danish Schizophrenia Registry
por: Baandrup, Lone, et al.
Publicado: (2016)

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
por: Gracias, Jessica, et al.
Publicado: (2022)

O9.1. CANNABIS AND OTHER SUBSTANCE USE DISORDERS PREDICT CONVERSION FROM SCHIZOTYPAL DISORDER TO SCHIZOPHRENIA
por: Hjorthoj, Carsten, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2n3fk90tdmiksu4jupe23m1qp4